Characteristics of Patients with Persistent COVID-19 Symptoms and Unscheduled Return Visits to a Centre for COVID-19 Evaluation
This retrospective study aimed to evaluate the characteristics of patients with long COVID syndrome. This study included 457 adults who had at least one persistent symptom after COVID-19 infection. The median time interval between the last SARS-CoV-2 infection and emergency room presentation was 3 m...
Gespeichert in:
Veröffentlicht in: | Diseases 2024-08, Vol.12 (9), p.199 |
---|---|
Hauptverfasser: | , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | This retrospective study aimed to evaluate the characteristics of patients with long COVID syndrome.
This study included 457 adults who had at least one persistent symptom after COVID-19 infection.
The median time interval between the last SARS-CoV-2 infection and emergency room presentation was 3 months. Older patients had comorbidities (61.7 vs. 44.9 years,
< 0.0001), moderate or severe forms of COVID-19 (61.2 vs. 50.9 years,
< 0.0001), and respiratory symptoms (56.1 vs. 52.0 years,
= 0.0027). Non-vaccinated patients were older than vaccinated patients (56.0 vs. 51.5 years,
= 0.0008) and had residual lung abnormalities following COVID-19 infection (51.5% vs. 36.8%,
< 0.003). The time interval between the last SARS-CoV-2 infection and the hospital evaluation was shorter for vaccinated patients (3.2 vs. 3.9 months,
< 0.0001) and those with mild forms (3.3 vs. 4.12 months,
= 0.0001) versus non-vaccinated individuals. After the last SARS-CoV-2 infection, 107 patients developed impaired fasting glucose, impaired glucose tolerance, or diabetes mellitus, being patients with already known chronic diseases (
= 0.0002), or hypertension (
= 0.001).
Our study pointed out the heterogeneity of symptoms following COVID-19, and they are associated with age, vaccination status, or severity of SARS-CoV-2 infection. |
---|---|
ISSN: | 2079-9721 2079-9721 |
DOI: | 10.3390/diseases12090199 |